The Efficacy and Safety of Telitacicept and Belimumab in Active Lupus Nephritis in the Real World: a Prospective Cohort Study
Clinical trial NCT05588830 · UNKNOWN
Trial details
- NCT number
- NCT05588830
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-10-20
- Primary completion
- 2023-10-20
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.